Skip to main content
Clinical Trials/NCT03169686
NCT03169686
Completed
Not Applicable

The Efficacy of WeChat Based Interventions ('WeChat WeQuit' Program) for Smoking Cessation in China: a Randomized Trial

Sir Run Run Shaw Hospital1 site in 1 country2,000 target enrollmentMarch 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cigarette Smoking
Sponsor
Sir Run Run Shaw Hospital
Enrollment
2000
Locations
1
Primary Endpoint
Biochemically Validated Continuously Abstinence
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This proposed project is to assess whether WeChat-based smoking cessation interventions ('WeChat WeQuit' program) will be effective at helping people in China who smoke, to quit.

Registry
clinicaltrials.gov
Start Date
March 19, 2020
End Date
November 16, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yanhui Liao

Attending Psychiatrist

Sir Run Run Shaw Hospital

Eligibility Criteria

Inclusion Criteria

  • Daily Chinese cigarette smokers.
  • 18 years of age and older living.
  • Being able to read and write in Chinese.
  • Owning a smartphone and knowing how to use WeChat.
  • Willing to make an attempt to quit smoking in the next month.
  • Willing to provide informed consent to participate in the study.

Exclusion Criteria

  • Nonsmokers.
  • Smokers without attempt to quit.
  • Below 18 years old.
  • Unable to use smartphone and WeChat.
  • Unable to read and write in Chinese.

Outcomes

Primary Outcomes

Biochemically Validated Continuously Abstinence

Time Frame: 26 weeks

The primary outcome will be biochemical validation of self-reported 26-week continuous smoking abstinence

Secondary Outcomes

  • Self-reported 7-day Point Abstinence(26 weeks)
  • Self-reported Continuous Abstinence(26 weeks)

Study Sites (1)

Loading locations...

Similar Trials